MAKO Surgical Corp. 4
4 · MAKO Surgical Corp. · Filed Dec 17, 2013
Insider Transaction Report
Form 4
Delevic Ivan
SVP Strategic Mktg&Bus Develop
Transactions
- Disposition to Issuer
Employee Stock Option (right to buy)
2013-12-17−35,000→ 0 totalExercise: $36.43Exp: 2022-02-23→ Common Stock (35,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2013-12-17$18.59/sh−55,000$1,022,450→ 0 totalExercise: $11.41Exp: 2023-02-21→ Common Stock (55,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2013-12-17$23.10/sh−71,500$1,651,650→ 0 totalExercise: $6.90Exp: 2019-04-27→ Common Stock (71,500 underlying) - Disposition to Issuer
Common Stock
2013-12-17$30.00/sh−4,118$123,540→ 0 total - Disposition to Issuer
Employee Stock Option (right to buy)
2013-12-17$18.05/sh−63,000$1,137,150→ 0 totalExercise: $11.95Exp: 2020-02-04→ Common Stock (63,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2013-12-17$13.68/sh−65,000$889,200→ 0 totalExercise: $16.32Exp: 2021-02-03→ Common Stock (65,000 underlying)
Footnotes (3)
- [F1]Includes shares acquired under the issuer's 2008 Employee Stock Purchase Plan.
- [F2]Pursuant to the Agreement and Plan of Merger ("Merger Agreement"), dated September 25, 2013, by and among the issuer, Stryker Corporation, and Lauderdale Merger Corporation, each share of the issuer's common stock was exchanged for a cash payment of $30.00.
- [F3]Pursuant to the Merger Agreement, each outstanding stock option, whether vested or unvested, was canceled in exchange for a cash payment equal to the amount, if any, by which $30.00 exceeded the exercise price payable per share under each such stock option.